BlossomHill Therapeutics, (BLSM) news
Recent news
Blossomhill shares indicated to open at $15.75 each, IPO $16
AInvest Wire · Aug 7, 2026Blossomhill shares indicated to open at $15.97 each, IPO $16
BlossomHill Therapeutics, Inc. (NASDAQ:BLSM) priced its initial public offering at $16.00 per share, raising $150.0 million in gross proceeds before underwriting discounts and offering expenses. The shares began trading on The Nasdaq Global Select Market on August 7, 2026, with shares indicated to…
AInvest Wire · Aug 7, 2026BlossomHill Therapeutics - prices upsized IPO of 9,375,000 shares at $16 per share
BlossomHill Therapeutics has priced its upsized initial public offering (IPO) at $16 per share, offering a total of 9,375,000 shares, according to recent filings. This represents an increase from earlier estimates, which had outlined a range of $15 to $17 per share for 7.8 million shares, with the…
AInvest Wire · Aug 7, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.